Goldman Sachs Group Inc. and its affiliates have reported an indirect stake of 3.24% in QIAGEN (QGEN) through a recent AFM filing. This disclosure highlights a significant institutional holding in the life sciences company.
Goldman Sachs Discloses 3.24% Indirect Stake in QIAGEN
institutional-holdingsequity-stakeGoldman-SachsQIAGEN



